USA v. Craft, No. 22-3015 (7th Cir. 2024)
Annotate this Case
Justia Opinion Summary
Want to stay in the know about new opinions from the Seventh Circuit US Court of Appeals?
Sign up for free summaries delivered directly to your inbox. Learn More ›
You already receive new opinion summaries from Seventh Circuit US Court of Appeals. Did you know we offer summary newsletters for even more practice areas and jurisdictions? Explore them here.
In October 2019, Randall Craft pleaded guilty to one count of conspiracy to distribute over fifty grams of methamphetamine. He was sentenced to 150 months in prison and five years of supervised release. The district court applied two sentencing enhancements: one for maintaining a premises for the purpose of manufacturing or distributing a controlled substance, and another for Craft's role as a manager or supervisor of the scheme.
The district court's decision was appealed to the United States Court of Appeals for the Seventh Circuit. The appellate court found that the district court erred in applying the premises enhancement, as the record did not support the conclusion that Craft used his home for the primary or principal purpose of manufacturing or distributing drugs. However, the court agreed with the district court's application of the two-level role enhancement, given Craft’s extensive role in the conspiracy.
Therefore, the United States Court of Appeals for the Seventh Circuit vacated Craft’s sentence and remanded his case to the district court for resentencing, taking into account the appellate court's findings regarding the two sentencing enhancements.
Download PDF
In the United States Court of Appeals For the Seventh Circuit ____________________ No. 22-3015 UNITED STATES OF AMERICA, Plaintiff-Appellee, v. RANDY SHANE CRAFT, Defendant-Appellant. ____________________ Appeal from the United States District Court for the Central District of Illinois. No. 2:19-cr-20027 — Michael M. Mihm, Judge. ____________________ ARGUED DECEMBER 1, 2023 — DECIDED APRIL 22, 2024 ____________________ Before WOOD, ST. EVE, and LEE, Circuit Judges. LEE, Circuit Judge. In October of 2019, Randall Craft pleaded guilty to one count of conspiracy to distribute over fty grams of methamphetamine in violation of 21 U.S.C. § 846, 21 U.S.C. § 841(a)(1), and 21 U.S.C. § 841(b)(1)(A). Craft was sentenced to 150 months in prison followed by ve years of supervised release. When calculating the guidelines range, the district court applied two sentencing enhancements. First, it applied a two-level enhancement for maintaining a 2 No. 22-3015 premises for the purpose of manufacturing or distributing a controlled substance under § 2D1.1(b)(12) of the United States Sentencing Guidelines. Second, it applied a two-level enhancement for Craft’s role as a manager or supervisor of the scheme under § 3B1.1 of the Guidelines. Because the record does not support the conclusion that Craft used his home for the primary or principal purpose of manufacturing or distributing drugs, we conclude that the district court erred in applying the premises enhancement. On the other hand, given Craft’s extensive role in the conspiracy, we agree with the district court’s application of the two-level role enhancement. Thus, we vacate Craft’s sentence and remand his case to the district court for resentencing. I. Background Craft and his girlfriend, Tracy Christian, lived together in Balch Springs, Texas, a suburb of Dallas. In late 2015, Craft met Frank Sha er and started selling him methamphetamine that Sha er would transport to Illinois and sell. At rst, Craft sold Sha er two ounces of methamphetamine at a time, but the quantity quickly increased to a half pound or full pound per transaction. During this period, Sha er was also in and out of prison and house arrest. Thus, to carry on the operation, Sha er enlisted others to help him obtain and transport the drugs, including two individuals named Jacob Burns and Austin Carey. In late May 2018, Sha er was released on parole, and he moved into Craft’s home in Balch Springs, where he lived with Craft, Christian, and Craft’s son. While Sha er lived there, Craft supplied him with methamphetamine around thirty times, and each time Sha er would transport the drugs to Illinois for distribution. Most of the time, Craft handed the No. 22-3015 3 drugs to Sha er at a nearby gas station, but on several occasions, Craft gave the drugs to Sha er when they were both at Craft’s house. Once Sha er received the drugs from Craft, he usually stored them at Craft’s house until he left for Illinois, typically less than twenty-four hours later. After distributing the drugs in Illinois, Sha er returned the proceeds from the sales to Craft and Christian, either directly or via wire service. Craft paid the rent and utilities for his home with the proceeds, then he split the remainder evenly with Sha er. Craft did not store his supply of drugs at the house, nor did he regularly sell to customers from the house. Sha er left Craft’s house in October 2018 and spent a few weeks in Illinois. While in Illinois, Sha er was arrested for possessing a loaded rearm and one ounce of methamphetamine. After waiving his Miranda rights, he admitted to the police that he was distributing drugs and that Craft was his supplier. Burns and Carey also had been arrested in the preceding months, and investigations following their arrests revealed to law enforcement that Craft and Christian had been supplying them methamphetamine as well. In April 2019, a grand jury indicted Craft and Christian on one count of conspiracy to distribute over fty grams of methamphetamine in violation of 21 U.S.C. § 846, 21 U.S.C. § 841(a)(1), and 21 U.S.C. § 841(b)(1)(A). Craft pleaded guilty in October 2019 without a plea agreement. Sha er, Burns, and Carey were all indicted on the same charge, but in separate cases. In anticipation of Craft’s sentencing hearing, the probation o cer issued a presentence report (PSR). The PSR placed 4 No. 22-3015 Craft’s base o ense level at 32, to which it added a two-level enhancement for maintaining a premises for the purpose of distributing methamphetamine under U.S.S.G. § 2D1.1(b)(12) and a four-level enhancement under U.S.S.G. § 3B1.1(a) for Craft’s role in the o ense as an organizer or leader of a criminal activity involving ve or more participants. After a threelevel reduction for acceptance of responsibility, Craft’s total o ense level was 35. With a criminal history score of four, the PSR recommended a guidelines range of 210 to 262 months of imprisonment. Craft initially only objected to the application of the premises enhancement, but he added an objection to the organizer or leader enhancement during his initial sentencing hearing. The district court gave Craft an opportunity to le a written objection regarding that enhancement. Meanwhile, the district court heard evidence as to the premises enhancement, and the government called Sha er to testify about his involvement with Craft and Craft’s role within the conspiracy. After this initial hearing, the parties briefed the application of the leadership enhancement, then they reconvened and resumed the sentencing hearing. At the hearing, the district court adopted the factual ndings of the PSR. Although the court considered it a “very close question,” it overruled Craft’s objection to the application of the premises enhancement. In reaching this conclusion, the court credited the fact that Craft had used the proceeds of the drug sales to pay for his rent and utilities. The district court also noted that Craft had no other income and that, on several occasions, Craft had delivered methamphetamine to Sha er at the house. As for the leadership enhancement, the district court found that the record did not support the PSR’s No. 22-3015 5 recommendation to apply a four-level enhancement for Craft’s role as an organizer or leader. Nonetheless, the court found that the record supported a nding that Craft was a manager or supervisor and applied a two-level enhancement for Craft’s role in the o ense. To support this nding, the court observed that Craft played a “critical role” in the conspiracy. The court further noted that Craft had supplied the drugs to Sha er and that Craft knew Sha er would later sell them. The district court’s ndings placed Craft at an o ense level of 33, which resulted in a guidelines range of 168 to 210 months of imprisonment. In the end, the district court sentenced Craft to a below-guideline sentence of 150 months to be followed by a ve-year term of supervised release. Craft appeals. II. Analysis Craft raises two challenges to his sentence. First, he argues that the district court erred when it applied a two-level premises enhancement under U.S.S.G. § 2D1.1(b)(12). Second, Craft maintains that the district court erred by applying a two-level enhancement for his role in the o ense under U.S.S.G. § 3B1.1. We address each of Craft’s arguments in turn. A. Premises Enhancement Craft rst challenges the district court’s application of the premises enhancement under U.S.S.G. § 2D1.1(b)(12). When considering a challenge to U.S.S.G. § 2D1.1(b)(12)’s premises enhancement, we review the district court’s application of the enhancement de novo and its underlying factual ndings for 6 No. 22-3015 clear error. United States v. Flores-Olague, 717 F.3d 526, 530 (7th Cir. 2013). The Guidelines provide for a two-level enhancement if “the defendant maintained a premises for the purpose of manufacturing or distributing a controlled substance.” U.S.S.G. § 2D1.1(b)(12). The application notes to § 2D1.1(b)(12) provide that, for the enhancement to apply, manufacturing or distributing drugs need not be the “sole purpose” for which the premises was maintained. U.S.S.G. § 2D1.1 cmt. n.17. At the same time, manufacturing or distributing drugs must at least be “one of the defendant’s primary or principal uses for the premises, rather than one of the defendant’s incidental or collateral uses for the premises.” Id. The application notes further provide that, to determine whether distributing a controlled substance was a primary versus collateral use of the premises, sentencing courts should ask “how frequently the premises was used by the defendant for manufacturing or distributing a controlled substance and how frequently the premises was used by the defendant for lawful purposes.” Id. However, courts are not required to employ a “simple balancing test” that compares the frequency of lawful and unlawful activities. United States v. Contreras, 874 F.3d 280, 284 (7th Cir. 2017). This is because “such a test would immunize every family home that is also used for drug distribution.” Id. (citing Flores-Olague, 717 F.3d at 533). Instead, the sentencing court is to consider “both the frequency and signi cance of the illicit activities, including factors such as quantities dealt, customer interactions, keeping ‘tools of the trade’ and business records, and accepting payment.” Id. (quoting Flores-Olague, 717 F.3d at 533). No. 22-3015 7 As an initial matter, the government does not argue (nor is there evidence in the record to suggest) that Craft ever manufactured methamphetamine in the home. Thus, because the Guideline requires a defendant to have “maintained a premises for the purpose of manufacturing or distributing a controlled substance,” the district court’s application of the premises enhancement must rest on Craft’s use of the home to distribute methamphetamine. U.S.S.G. § 2D1.1(b)(12) (emphasis added). Here, the record is insu cient to support a nding that Craft maintained the premises for the “primary or principal” purpose of distributing controlled substances. The government has presented no evidence that Craft received or stored methamphetamine at his home for later distribution. And besides the “several” occasions when Craft transferred the methamphetamine to Sha er at the home, there is no evidence that Craft sold methamphetamine to anyone else at or from the home. Nor did law enforcement o cers discover any other evidence in the home, such as drug tra cking paraphernalia, that might otherwise indicate that Craft primarily used the premises for drug distribution. We also nd it signi cant that, besides the few occasions when Craft handed the drugs to Sha er when they were both at the home, Craft most often transferred the drugs to Sha er at a local gas station. The fact that Craft went out of his way to deliver the drugs to Sha er away from his house (despite the fact that they both lived there) strongly indicates that distributing drugs was not a “primary or principal” use of the premises. And to the extent that Craft gave Sha er the drugs on only “several occasions” when they were both home, these 8 No. 22-3015 transfers were merely incidental to Craft’s (and Sha er’s) residence there. Consider our recent decisions in this area. In Flores-Olague, the defendant sold and stored drugs at his home on a daily basis over a three-year period and did not attempt to demonstrate to the court that there were any limitations on these activities. 717 F.3d at 533. And, unlike the present case, “no other locations for drug dealing” appeared in the record. Id. Based on these facts, we found that application of the twopoint premises enhancement was “clearly warranted.” Id. We similarly a rmed the district court’s application of the premises enhancement in Contreras, 874 F.3d at 284. In that case, the defendant’s activities were less frequent than in FloresOlague—rather than distributing drugs from the home on a daily basis, the defendant distributed drugs at his home on eight occasions, most occurring within a two-month period. Id. Still, we found that other facts made up for the relative infrequency of the defendant’s sales from the home. For example, the “government also presented evidence that drugs were shipped to and stored at Contreras’s home, that Contreras accepted payment for drugs at his home, and that other codefendants met at Contreras’s home to settle a narcotics debt.” Id. We also pointed to the large quantities dealt each time in upholding the enhancement. Id. By contrast, the evidence that Craft maintained the home for the primary or principal purpose of distributing drugs is scant. Craft handed the drugs to Sha er at the home as few as three times over the ve-month period Sha er lived there— even less frequently than the eight transactions in two months in Contreras. And unlike in Contreras, here we lack other evidence that might otherwise make up for the relative No. 22-3015 9 infrequency of the transactions. Craft did not ship drugs to his home, nor did he personally store his supply there. And most of his transactions with Sha er occurred outside of his home at a gas station. Unlike in Flores-Olague and Contreras, there is no evidence that Craft used his home for the primary or principal purpose of distributing drugs. Pressing its point, the government argues that the district court properly applied the enhancement because Craft had no other job and made his entire livelihood selling methamphetamine. It is true that, in the past, we have looked to whether a defendant makes their livelihood selling drugs when determining whether the premises enhancement should apply. See, e.g., United States v. Sanchez, 710 F.3d 724, 732 (7th Cir. 2013), vacated on other grounds, 571 U.S. 801 (2013); Flores-Olague, 717 F.3d at 534; United States v. Win eld, 846 F.3d 241, 243 (7th Cir. 2017); United States v. Hopper, 934 F.3d 740, 765 (7th Cir. 2019). But, while this fact can move the needle somewhat by placing a defendant’s home-centered drug tra cking activity in context, we have never relied on it as the primary driver of the premises enhancement. This issue rst came up in Sanchez, 710 F.3d at 731–32. There, we pointed to evidence that the defendant “regularly sold and stored drugs in his home” over a two-year period. Id. at 731. Then, to evaluate whether the activities were significant or frequent enough to consider them a principal use of the home, we noted that the defendant “was the largest wholesaler in a conspiracy responsible for nearly $2.5 million in drug tra cking” and that he “had no legitimate job and no source of income beyond his drug sales.” Id. at 732. As a result, we concluded that the activities must have been signi cant, in part because of the sheer volume of sales and the 10 No. 22-3015 defendant’s complete reliance on drug sales for his livelihood. And from this, we reasoned that the defendant’s distribution must have been a principal use of the premises, thus warranting application of the enhancement. Our later cases have largely followed the same approach, using a defendant’s reliance on drug sale proceeds as one of many factors to suss out whether he had used his home for the primary or principal purpose of distributing drugs. In Win eld, for example, the defendant sold drugs to a con dential informant at his apartment on four di erent occasions over a twelve-week period. 846 F.3d at 241. When law enforcement o cers searched his home pursuant to a warrant, they found a signi cant amount of cash, drug paraphernalia, heroin, and methamphetamine. Id. at 242. Later, Win eld admitted that he had ushed any drugs he had down the toilet when he realized that police o cers were coming to search his home. Id. It was against this backdrop that we observed that Win eld had made his livelihood selling drugs and, as a result, that we thought it reasonable for the district court to conclude that Win eld “must have stored or sold additional quantities of drugs at his apartment than the relatively modest amounts recovered by police.” Id. at 243. Together, these facts supported the conclusion that “Win eld’s drug-related uses for his apartment were not merely ‘incidental’ to his residence there.” Id.; see also Flores-Olague, 717 F.3d at 533–34 (considering a defendant’s partial livelihood selling drugs only to determine the “frequency and signi cance of illicit activities at the premises”). These opinions teach that whether a defendant makes his livelihood selling drugs is not su cient, by itself, to support the application of the premises enhancement. After all, the No. 22-3015 11 fact that a defendant earns his entire livelihood selling drugs does not necessarily mean he manufactures or sells those drugs at his home. Any other conclusion would be divorced from the text of the enhancement, which provides for a twolevel enhancement only if the premises is maintained for the purpose of “manufacturing or distributing” a controlled substance. U.S.S.G. § 2D1.1(b)(12) (emphasis added). Here, the evidence does not leave us guessing as to whether distribution from Craft’s home was signi cant or frequent. To the contrary, the evidence shows (and the government does not dispute) that Craft’s distribution from the home was limited in scope—he only transferred the drugs to Sha er there on “several” occasions, while he gave Sha er drugs outside the home on many more. And there is no evidence that he sold drugs to anyone else from the home. In these circumstances, Craft’s livelihood selling drugs cannot, standing alone, serve as the basis for the district court’s application of the premises enhancement. 1 Finally, the government insists that Sha er’s storage of the drugs at the home for up to twenty-four hours before he left for Illinois supports the application of the premises enhancement. But we also see Sha er’s eeting storage of the drugs there as an “incidental” use of the premises—he only stored 1 The district court also found it important that the proceeds of the drug sales were used to pay the household expenses. But for the same reasons just discussed, this evidence cannot by itself support the application of the premises enhancement. A defendant might use the proceeds of his drug sales to pay rent, but doing so does not suggest that drugs were manufactured in or distributed from the home. 12 No. 22-3015 them there for less than twenty-four hours before he left for Illinois and because he was living with Craft. In the end, Craft’s sales of drugs to Sha er in his home were limited to “several” occasions, while most of Craft’s sales to Sha er occurred outside of his home. Thus, the record does not support a nding that Craft “maintained a premises for the purpose of manufacturing or distributing a controlled substance,” and the district court erred in applying the twolevel enhancement. U.S.S.G. § 2D1.1(b)(12). B. Craft’s Role in the O ense Craft next argues that the record does not support the application of a two-level enhancement under U.S.S.G. § 3B1.1 for being a manager or supervisor in the drug operation. When considering a challenge to an enhancement under § 3B1.1 of the Guidelines, we review de novo whether the factual ndings of the district court adequately support the application of the enhancement. United States v. House, 883 F.3d 720, 723 (7th Cir. 2018). We review the underlying factual ndings for clear error. Id. U.S.S.G. § 3B1.1 provides for sentencing enhancements based on a defendant’s role in the o ense. If a crime involved ve or more participants or was “otherwise extensive,” a defendant receives a four-level enhancement if he is an “organizer or leader” of the scheme under § 3B1.1(a), and a threelevel enhancement if he is a “manager or supervisor” under § 3B1.1(b). If the defendant was an “organizer, leader, manager, or supervisor” but the crime did not involve ve or more participants and is not “otherwise extensive,” a defendant receives a two-level enhancement under § 3B1.1(c). No. 22-3015 13 Although the Guidelines do not expressly de ne manager or supervisor, we have said that “a manager or supervisor should be straightforwardly understood as simply someone who helps manage or supervise a criminal scheme.” House, 883 F.3d at 724 (quoting United States v. Grigsby, 692 F.3d 778, 790 (7th Cir. 2012)). In other words, our primary goal is to make a “commonsense judgment about the defendant’s relative culpability given his status in the criminal hierarchy.” Id. (quoting United States v. Dade, 787 F.3d 1165, 1167 (7th Cir. 2015)). We think there is enough evidence in the record to support application of the manager or supervisor enhancement here. Several facts indicate that Craft managed or supervised others in carrying out the operation and, therefore, is more culpable than other members of the conspiracy. For example, once the distributors sold the methamphetamine they received from Craft, Craft managed the pro ts, paid the household bills, and split the proceeds evenly among himself and Sha er. See Grigsby, 692 F.3d at 791 (a rming application of the manager or supervisor enhancement where the defendant took custody of the proceeds and divided them among coconspirators); see also House, 883 F.3d at 724 (same). Craft also enlisted Sha er and Burns to the conspiracy. See United States v. Watts, 535 F.3d 650, 660 (7th Cir. 2008) (upholding the application of § 3B1.1(c) because the defendant recruited his wife into a bank fraud scheme). In addition, Carey reported to law enforcement agents that Craft and Sha er had closed-door meetings to discuss their drug business, suggesting that Craft and Shaffer were higher on the hierarchy relative to Carey and the others. See United States v. Hawkins, 796 F.3d 843, 872 (8th Cir. 2015) (citing defendant’s participation in closed-door 14 No. 22-3015 meetings as evidence supporting the district court’s application of the manager or supervisor enhancement). Craft retorts that the enhancement should not apply because he did not direct Sha er or anyone else where to sell drugs. But the district court adopted the PSR’s factual ndings without objection, and the PSR found that Craft directed Christian, demonstrating that Craft had exercised at least some level of control over other participants in the operation. We have said that, “[t]o apply the enhancement, a court need only nd that the defendant directed at least one other person.” United States v. Beechler, 68 F.4th 358, 369 (7th Cir. 2023) (citing United States v. Hernandez, 309 F.3d 458, 463 (7th Cir. 2002)). In any event, a defendant may still be eligible for the enhancement even without evidence that they controlled others. See Dade, 787 F.3d at 1167 (stating that control is “just one measure”). Even if we were to disregard the PSR’s nding that Craft had directed Christian, we have other evidence suf cient to support a nding that Craft was a manager or supervisor—namely, that Craft managed the proceeds, recruited others to the conspiracy, and participated in closed-door meetings without other members of the conspiracy. Finally, Craft insists that his role in the operation was limited to sourcing the methamphetamine, which he says indicates he was not higher on the criminal hierarchy than other members of the operation. There is no doubt that, under our precedent, “[s]upplying drugs and negotiating the terms of their sale do not by themselves justify a Section 3B1.1 increase.” United States v. Weaver, 716 F.3d 439, 444 (7th Cir. 2013) (quoting United States v. Vargas, 16 F.3d 155, 160 (7th Cir. 1994)). But, as discussed, here we have additional evidence No. 22-3015 15 that Craft was higher on the criminal hierarchy compared to the others. Our nding that Sha er was a manager or supervisor does not solely rest on Craft’s role in supplying the drugs. Accordingly, we nd that the district court did not err in applying the manager or supervisor enhancement to Craft’s sentence. 2 III. Conclusion For the foregoing reasons, we VACATE the judgment of the district court and REMAND for resentencing consistent with this opinion. 2 We note that the district court applied a two-level enhancement instead of the three-level enhancement provided for in § 3B1.1(b) for managers or supervisors of crimes that involve five or more participants. Since the government did not file a cross-appeal, we do not reach this issue on appeal. Greenlaw v. United States, 554 U.S. 237, 244–45 (2008).
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
